HOMA-IR as a Screening Test in NAFLD

The aim of this study is to evaluate the role of HOMA-IR in diagnosis of NAFLD in patients with type 2 DM.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

NAFLD Digestive System Diseases Fatty Liver Liver Diseases Non-alcoholic Fatty Liver Disease

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fayoum university hospital

Al Fayyum, 63514, Egypt

About this study

this study is a retrospective cohort study included 100 patients with type 2 DM from the outpatient clinic of internal medicine department at Fayoum University Hospital. They were divided into two equal groups according to the presence of NAFLD by ultrasound. All patients were subjected to history taking, clinical examination and investigations which included: ALT, AST, total cholesterol, TG, FBG and fasting insulin level,HOMA-IR(Homeostatic Model Assessment for Insulin Resistance) assessment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diabetes obesity

Exclusion criteria

use of alcohol

Treatment and study plan

Primary outcomes

The correlation between HOMA-IF and NAFLD

Time frame: 6 months

Find a statistically significant correlation between HOMA IR and NAFLD in diabetics

Sponsors and collaborators

Lead sponsor

Fayoum University

Other

Registry information

Official study title

Is HOMA-IR(Homeostatic Model Assessment for Insulin Resistance) a Potential Screening Test for Non-alcoholic Fatty Liver Disease in Adults With Type 2 DM?

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Sep 10, 2019
Registry last updated: Sep 12, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed